LevitasBio logo — Elevate your research with our groundbreaking Levitation Tec...

LevitasBio

Elevate your research with our groundbreaking Levitation Technology. Cell Isolation and Enrichment Done Right.

Founded 2017 United States Menlo Park, United States 46 employees Series Unknown Total: $72.76M Analytics, Biotechnology +2

General Information

Company Name LevitasBio
Founded Year 2017
Location United States Menlo Park, United States +1
Employees 46
Industries Analytics, Biotechnology, Health Care +1
Funding Stage Series Unknown
Social

Get notified when LevitasBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LevitasBio

LevitasBio is a pioneer in sample processing and analysis within the life sciences market, offering the revolutionary LeviCell system. This advanced technology allows for cellular research and analysis without altering or damaging the cells, preserving the original samples to provide true biological insights. Founded in 2017 and headquartered in the United States, LevitasBio recently secured a significant $11.76M Venture Round investment on 28 March 2024. With a focus on Analytics and Biotechnology, LevitasBio is poised to elevate research through its groundbreaking Levitation Technology, enabling precise cell isolation and enrichment. This investment underscores the potential and investor confidence in LevitasBio's innovative approach to advancing cellular research and analysis.

Taxonomy: Cell Isolation, Cell Enrichment, Levitation Technology, LeviCell System, Sample Processing, Cellular Research, Cellular Analysis, Magnetic Levitation Technology, Label-Free Analysis, Primary Samples, Sensitive Cell Types, Biological Signatures, Life Sciences, Research and Development, Innovative Technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 28 Mar 2024
Series C •••••• 3
Investor Investor Investor
24 Oct 2022
Series B •••••• 1
Investor
05 Jan 2021
Series A •••••• 1
Investor
03 Aug 2017

LevitasBio Alternatives & Competitors

LevitasBio vs

Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing tech...

Series E
9 employees
Analytics, Biotechnology
LevitasBio vs

Empowering breakthroughs in cellular research with sophisticated, automated technology for advanced...

Series Unknown
Biotechnology, Health and Wellness
LevitasBio vs

Innovating Cell Culture since 2015, xeno-free | Experts in Human Platelet Lysate | Home of the ELARE...

Series A
34 employees
Biotechnology, Health Care

FAQ About LevitasBio

Elevate your research with our groundbreaking Levitation Technology. Cell Isolation and Enrichment Done Right.
LevitasBio was founded in 2017.
LevitasBio is headquartered in Menlo Park, United States.
LevitasBio operates in the following industries: Analytics, Biotechnology, Health Care, Health and Wellness.
LevitasBio has approximately 46 employees.
LevitasBio has completed 4 funding rounds, raising a total of $72.76M. The latest funding stage is Series Unknown.
Top alternatives and competitors to LevitasBio include Cyntellect, InQ Biosciences, PL BioScience GmbH, Fluxion Biosciences, TOMOCUBE, INC.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LevitasBio and Cyntellect are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LevitasBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy